The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population

Gene

Volumn 527, Issue 2, 2013, Pages 565-569

  Kalkan, Göknur ^a   Karakus, Nevin ^a   Baş, Yalçin ^a   Takçi, Zennure ^a   Özuǧuz, Pinar ^b   Ateş, Ömer ^a   Yigit, Serbulent ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Alopecia; Alopecia areata; Genetic skin disorders; IL 4; Polymorphism

Indexed keywords

GENOMIC DNA; INTERLEUKIN 4;

ADULT; ALOPECIA AREATA; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TURKEY (REPUBLIC); VARIABLE NUMBER OF TANDEM REPEAT;

AA; ALOPECIA; ALOPECIA AREATA; ALOPECIA TOTALIS; ALOPECIA UNIVERSALIS; ANALYSIS OF VARIANCE; ANOVA; AT; AU; CI; CONFIDENCE INTERVAL; CYTOTOXIC T CELLS; END-STAGE RENAL DISEASE; ESRD; GENETIC SKIN DISORDERS; HLA; HUMAN LEUKOCYTE ANTIGEN; IL; IL-4; INTERLEUKIN; MS; MULTIPLE SCLEROSIS; NATURAL KILLER; NK; ODDS RATIO; OR; PCR; POLYMERASE CHAIN REACTION; POLYMORPHISM; RA; RHEUMATOID ARTHRITIS; SD; SINGLE-NUCLEOTIDE POLYMORPHISMS; SLE; SNPS; SPSS; STANDARD DEVIATION; STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES; SYSTEMIC LUPUS ERYTHEMATOSUS; T HELPER CELLS; TC CELLS; TH CELLS; TNF; TUMOR NECROSIS FACTORS ALPHA; VARIABLE NUMBER OF TANDEM REPEAT; VNTR;

ADULT; ALOPECIA AREATA; FEMALE; HUMANS; INTERLEUKIN-4; INTRONS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; TURKEY;

EID: 84881544113     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.05.086     Document Type: Article

References (37)

1. Alzolibani A.A. Epidemiologic and genetic characteristics of alopecia areata (part 1). Acta Dermatovenerol. Alp. Panonica Adriat. 2011, 20(4):191-198.
2. Alzolibani A.A., Zari S., Ahmed A.A. Epidemiologic and genetic characteristics of alopecia areata (part 2). Acta Dermatovenerol. Alp. Panonica Adriat. 2012, 21(1):15-19.
3. Attia E.A., El Shennawy D., Sefin A. Serum interleukin-4 and total immunoglobulin E in nonatopic alopecia areata patients and HLA-DRB1 typing. Dermatol. Res. Pract. 2010, 2010:503587.
4. Bacharier L.B., Geha R.S. Molecular mechanisms of IgE regulation. J. Allergy Clin. Immunol. 2000, 105:547-558.
5. Bid H.K., Konwar R., Agrawal C.G., Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the North Indian population. Ind. J. Med. Sci. 2008, 62:259-266.
6. Del Prete G., et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 1988, 140:4193-4198.
7. Galbraith G.M., Pandey J.P. Tumor necrosis factor alpha (TNF-a) gene polymorphism in alopecia areata. Hum. Genet. 1995, 96:433-436.
8. Galbraith G.M., Palesch Y., Gore E.A., Pandey J.P. Contribution of interleukin 1beta and KM loci to alopecia areata. Hum. Hered. 1999, 49(2):85-89. (Mar).
9. Garg S., Messenger A.G. Alopecia areata: evidence-based treatments. Semin. Cutaneous Med. Surg. 2009, 28:15-18.
10. Ghoreschi K., et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 2003, 9:40-46.
11. Gilhar A., Shalaginov R., Assy B., Serafimovich S., Kalish R.S. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J. Invest. Dermatol. Symp. Proc. 1999, 4:207-210.
12. Gilhar A., et al. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin. Immunol. 2003, 106:181-187.
13. Imran M., et al. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Br. J. Dermatol. 2012, 167(2):314-323.
14. Kalish R.S., Gilhar A. Alopecia areata: autoimmunity the evidence is compelling. J. Investig. Dermatol. Symp. Proc. 2003, 8:164-167.
15. Kantarci O.H., et al. A population-based study of IL4 polymorphisms in multiple sclerosis. J. Neuroimmunol. 2003, 137(1-2):134-139. (Apr).
16. Katagiri K., Arakawa S., Hatano Y. In vivo levels of IL-4, IL-10, TGF-β1 and IFN-γ mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis. Arch. Dermatol. Res. 2007, 298:397-401.
17. Kidd P. Th1 /Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003, 8:223-246.
18. Lew B.L., Cho H.R., Haw S., Kim H.J., Chung J.H., Sim W.Y. Association between IL17A/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population. Ann. Dermatol. 2012, 24(1):61-65. (Feb).
19. Martinez-Mir A., et al. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am. J. Hum. Genet. 2007, 80:316-328.
20. Mcdonagh A.J., Snowden J.A., Stierle C., Elliott K., Messenger A.G. HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines. Br. J. Dermatol. 1993, 129:250-256.
21. Mittal R.D., Manchanda P.K. Association of interleukin (IL)-4 intron-3 and IL-6-174G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics 2007, 59:159-165.
22. Mout R., Willemze R., Landegent J.E. Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res. 1991, 19(13):3763. (Jul 11).
23. Nakamura M., Jo J., Tabata Y., Ishikawa O. Controlled delivery of T box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in aC3H/HeJ mouse model. Am. J. Pathol. 2008, 172(3):650-658. (Mar).
24. Nakashima H., et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immunol. 2002, 3:107-109.
25. Olsen E.A., et al. Alopecia areata investigational assessment guidelines - Part II. National Alopecia Areata Foundation. J. Am. Acad. Dermatol. 2004, 51:440-447.
26. Petukhova L., et al. Genome wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010, 466(7302):113-117. (Jul 1).
27. Redler S., et al. Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severealopecia areata. Br. J. Dermatol. 2012, 167(6):1360-1365. (Dec).
28. Rocken M., Racke M., Shevach E.M. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 1996, 17:225-231.
29. Safavi K.H., Muller S.A., Suman V.J., Moshell A.N., Melton L.J. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin. Proc. 1995, 70:628-633.
30. Schueller A.C., et al. Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis. Biol. Neonate 2006, 90:229-232.
31. Sobti R.C., Maithil N., Thakur H., Sharma Y., Talwar K.K. VEGF and IL4 gene variability and its association with the risk of coronary heart disease in north Indian population. Mol. Cell. Biochem. 2010, 341(1-2):139-148.
32. Teraki Y., Imanishi K., Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm.-Venereol. 1996, 76:421-423.
33. Thepen T., et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. Allergy Clin. Immunol. 1996, 97:828-837.
34. Tobin D.J. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J. Investig. Dermatol. Symp. Proc. 2003, 8:176-181.
35. Vandenbroeck K., et al. Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J. Neuroimmunol. 1997, 76:189-192.
36. Wu M.C., Huang C.M., Tsai J.J., Chen H.Y., Tsai F.J. Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003, 12:21-25.
37. Zhang J.G., Oliver R.F. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br. J. Dermatol. 1994, 130:405-414.